Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30003053HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS30003054HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS30007508HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS30019487HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS30048701HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS30048702HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS30048703HIVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS20027277HPVENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TVIS44030110HTLV-1ENSG00000105329.11protein_codingTGFB1NoNo7040P01137
TCGA Plot Options
Drug Information
GeneTGFB1
DrugBank IDDB01162
Drug NameTerazosin
Target IDBE0000984
UniProt IDP01137
Regulation Typeinducer
PubMed IDs23518907; 11170131
CitationsPapadopoulos G, Vlachodimitropoulos D, Kyroudi A, Kouloukoussa M, Perrea D, Mitropoulos D: Terazosin treatment induces caspase-3 expression in the rat ventral prostate. J Clin Med Res. 2013 Apr;5(2):127-31. doi: 10.4021/jocmr1215w. Epub 2013 Feb 25.@@Glassman DT, Chon JK, Borkowski A, Jacobs SC, Kyprianou N: Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia. Prostate. 2001 Jan 1;46(1):45-51.
GroupsApproved
Direct ClassificationN-arylpiperazines
SMILESCOC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Pathways
PharmGKBPA451612
ChEMBLCHEMBL611